About the UVM Cancer Center

The University of Vermont (UVM) Cancer Center was founded in 1974. The cancer center is a not-for-profit organization administratively located at the Larner College of Medicine with clinical partnerships across the University of Vermont Health Network and beyond.

Mission

The mission of the University of Vermont Cancer Center is to reduce the burden of cancer in Vermont, northeastern New York and across northern New England, through research, outstanding clinical care, community outreach and education.

Vision

Working together, affiliated members, clinicians, scientists, and community stakeholders will be leaders in facilitating transdisciplinary discovery and achieving cancer health equity in northern New England.

The Four Pillars

The Cancer Center is a research institute, a clinical care facility, an educational entity and a community organization all in one. Our four pillars - research, clinical care, education, and community outreach - supports the mission of the Center -- to reduce the burden on cancer in the catchment area. 

The four pillars related to each other

Location & Facilities

The cancer center is an official administrative unit of UVM's Larner College of Medicine. Our clinicians enjoy a clinical partnership with the University of Vermont Medical Center. This flagship academic medical center includes an Ambulatory Care Center, an Education and Conference Center, and a cancer center clinical facility which allows integrated, multidisciplinary services for cancer diagnosis, outpatient treatment, and post-treatment follow up.

Contact Us

The University of Vermont Cancer Center
The Courtyard at Given
4th Floor North
89 Beaumont Avenue
Burlington, VT  05405

Clinical contact: (802) 847-8400.

Administrative contact:

Phone: (802) 656-4414
Fax: (802) 656-8788
Email: cancer@uvmcc.med.uvm.edu

Communications

Innovations Newsletter 
View all issues
To receive a printed copy, email cancer@uvmcc.med.uvm.edu

Annual Report
2023 Annual Report | 2022 Annual Report

Patient Newsletter
Sign up form (bottom of the page)

X: @UVMcancercenter
Facebook: @UVMCancerCenter

Lester-Coll Quoted in Renal & Urology News Article on SBRT to Treat Prostate Cancer

October 16, 2023 by Lucy Gardner Carson

(OCTOBER 16, 2023) Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center, commented to Renal & Urology News about a study of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer.

Radiation oncologist Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center

(OCTOBER 16, 2023) Radiation oncologist Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center, commented to Renal & Urology News about a study of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer.

SBRT should be considered a new standard of care for low-and favorable-intermediate-risk prostate cancer, investigators concluded based on findings from the international phase 3 PACE-B trial presented at the American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting in San Diego.

Lester-Coll said the excellent outcomes observed in PACE-B reflect advances in patient immobilization, treatment planning, and image-guidance. “It’s a very important study in that the stereotactic option offers convenience and cost-effectiveness, providing patients with shorter, more accessible treatment while optimizing health care resources,” he said.

Read full story at Renal & Urology News